Clinical trial · Observational
Falls Risk Questionnaire in Older Adults With Cancer
Pilot Study of the Falls Risk Questionnaire in Older Adults With Cancer
NCT02204137CI-TRIAL-00027282completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research study is to look at the use of a series of questionnaires evaluating risk for falls in order to collect information that might be used to develop a larger study aiming to recognize who is more at risk for falls and how to best intervene to prevent falls in older adults with cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Geriatric Assessment | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cancer and Aging Research Group Geriatric Assessment | Other | — | UNRESOLVED |
| Falls Efficacy Scale-International (FES-1) | Other | — | UNRESOLVED |
| Falls Risk Questionnaire | Other | — | UNRESOLVED |
| Health Related Quality of Life using the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity Scale (FACT GOG/NTX) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Completion of Questionnaires
- description
- Participants will complete an assessment consisting of the Falls Risk Questionnaire, a primarily self-administered geriatric assessment (GA) developed by the Cancer and Aging Research Group, a quality of life scale (FACT GOG/NTX) and the Falls Efficacy Scale-International. Each questionnaire contains approximately 150 questions and will take between 30 minutes and one hour to complete.
- interventionNames
- Other: Falls Risk Questionnaire
- Other: Cancer and Aging Research Group Geriatric Assessment
- Other: Falls Efficacy Scale-International (FES-1)
- Other: Health Related Quality of Life using the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity Scale (FACT GOG/NTX)
Primary outcomes (1)
- measure
- Percent completion of the Fall Risk Questionnaire (FRQ) and the Cancer and Aging Research Group Geriatric Assessment (CARG GA) of enrolled patients
- timeFrame
- Day 1
- description
- The percent of patients who complete the assessment will be calculated. Successful completion will be defined as the completion of all items on the questionnaires. If more than 85% of subjects are able to complete the FRQ and CARG GA, the assessment will be deemed feasible.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Age 65 or older; 5 patients will be enrolled in each of the following age cohorts: 65-69, 70-74, 75-79, 80 and older * Diagnosis of cancer, any type * Currently receiving or anticipated to initiate systemic cancer therapy within 1 month, including endocrine therapy, chemotherapy or targeted therapies * Able to understand and willing to sign an IRB-approved written informed consent document Exclusion Criteria: * Unable to understand written English * Psychiatric illness/social situation that would limit compliance with the study requirements * Unable to walk.
References
Publications (0)
Data not yet available
No reference posted for this study.